We use cookies to measure traffic and show relevant ads. By clicking Accept you agree to our use of analytics and advertising cookies.
一家美国初创公司获得FDA批准，测试CRISPR疗法用于治疗先天性黑蒙症导致的失明。文章详细介绍了细节、风险和前景。
